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HDACRecognition memory enables us to judge whether we have encountered a stimulus before and to recall
associated information, includingwhere the stimuluswas encountered. The perirhinal cortex (PRh) is required
for judgment of stimulus familiarity, while hippocampus (HPC) and medial prefrontal cortex (mPFC) are
additionally involved when spatial information associated with a stimulus needs to be remembered. While
gene expression is known to be essential for the consolidation of long-term recognition memory, the
underlying regulatory mechanisms are not fully understood. Here we investigated the roles of two epigenetic
mechanisms, DNA methylation and histone deacetylation, in recognition memory. Infusion of DNA
methyltransferase inhibitors into PRh impaired performance in novel object recognition and object-in-place
tasks while infusions into HPC or mPFC impaired object-in-place performance only. In contrast, inhibition of
histone deacetylases in PRh, but notmPFC, enhanced recognitionmemory. These results support the emerging
role of epigenetic processes in learning and memory.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Recognition memory is a fundamental process that enables us to
judge whether we have encountered something before. It is
considered to rely on multiple processes, depending on the type of
information to be remembered including stimulus familiarity dis-
crimination, the ability to judge the relative familiarity of a single
item, stimulus location or associative recognition, which involves
remembrance of a stimulus with its associated contextual informa-
tion. The perirhinal cortex (PRh) is essential for familiarity discrim-
ination (Ennaceur et al., 1996; Aggleton et al., 1997; Mumby et al.,
2002a) while associative recognition involves interactions between
the PRh and the hippocampus (HPC) and medial prefrontal cortex
(mPFC) (Mitchell and Laiacona, 1998; Mumby et al., 2002b; Barker
et al., 2007; Good et al., 2007; Barker and Warburton, 2011).
While long-term recognition memory formation has been shown
to require expression of immediate early genes and a number of
transcription factors (Zhu et al., 1995; Bozon et al., 2003; Warburton
et al., 2005; Soulé et al., 2008;McNulty et al., 2012; Seoane et al., 2012;armaceutical Sciences, Cardiff
Cardiff CF10 3NB, UK.
Inc. This is an open access article uBarbosa et al., 2013; Beer et al., 2013), little is known about how these
genes are regulated. Epigenetic regulation processes have been shown
to be important for long term memory. For example, DNA methyla-
tion, the methylation of cytosines by DNA methyltransferases
(DNMTs), is a transcriptional regulatory mechanism that has recently
been implicated in single-item recognition memory (Morris et al.,
2014; Tomizawa et al., 2015) and associative fear conditioning (Miller
and Sweatt, 2007; Lubin et al., 2008; Halder et al., 2016). Furthermore
DNMT inhibition in PRh or HPC has been shown to affect object-place
associative memory (Mitchnick et al., 2015).
Another epigenetic mechanism strongly implicated in memory
formation is the acetylation of lysine residues on histone tails in
chromatin, a process mediated by histone acetyl transferases (HATs)
and histone deacetylases (HDACs) (Graff and Tsai, 2013). Histone
acetylation has been shown to be critical for the formation of fear and
spatial memory (Guan et al., 2009; Sui et al., 2012) and transgenic mice
in which HAT activity is inhibited showed significant impairments in
spatial memory and novel object recognition. HAT inhibition in the PRh
or theHPCwas also found to impair object-place associative recognition
memory (Mitchnick et al., 2016). Conversely, HDAC inhibition has been
shown to rescue the deficit in object recognitionmemory observed after
HAT mutation (Korzus et al., 2004) and to enhance object recognition
memory following a shortened same phase which did not result in
robustmemory in control animals (Fontán-Lozano et al., 2008; Stefanko
et al., 2009; Haettig et al., 2011).nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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histone acetylation are important for long-term memory, this study
investigated the contribution of DNMTs and HDACs in the HPC, PRh
and mPFC to long-term single-item and associative recognition
memory, as there is little evidence currently available concerning
the contribution of DNMTs and HDACs in discrete brain areas to
recognition memory encoding and consolidation. Previous studies
have shown that DNMT levels are increased during memory
consolidation (Miller and Sweatt, 2007; Monsey et al., 2011; Morris
et al., 2014). DNMT inhibitors, applied immediately after fear memory
training could block conditioning-associated increases in gene
methylation 1 h after the training session (Miller and Sweatt, 2007),
suggesting that DNMTs exert functional effects during consolidation.
In comparison, increased histone acetylation has been shown to
commence during memory encoding in normal animals (Korzus et al.,
2004; Fontán-Lozano et al., 2008; Wang et al., 2014). Hence, we
hypothesised that inhibiting DNMT activity in vivo in the HPC, PRh or
mPFC after the sample phase of a recognition memory task would
impair recognition memory in the rat, and that conversely inhibiting
HDAC activity in the PRh and mPFC before the sample phase would
lead to enhancements in recognition memory.2. Materials and methods
2.1. Animals
Adult male Lister Hooded rats were used for all experiments. Rats
were three months old and weighing at least ~350 g at the time of
surgery. All groups of animals undergoing the same cannulation
procedure were littermates. Animals were not balanced for age
among the various experiments, however all behavioural testing took
place when rats were between three months and eleven months of
age. Rats were housed in pairs under a 12 h light/dark cycle, with food
and water available ad libitum. Experiments were performed during
the dark phase. All animal procedures were performed in accordance
with United Kingdom Animals Scientific Procedures Act (1986) and
associated guidelines.2.2. Surgery
Rats were implantedwith bilateral cannulae aimed at the HPC, PRh
or mPFC. To this end, rats were anaesthetised with isoflurane (4% for
induction, 2–3% for maintenance) and placed into a stereotaxic frame
to achieve a flat skull. Stainless-steel guide cannulae (26 gauge,
Plastics One) were inserted through burr holes in the skull and fixed
in place by stainless-steel skull screws (Plastics One) and bone
cement. Cannula locations depended on whether cannulae were
implanted individually or in combination with cannulae for a second
brain region. HPC cannulae were inserted at: anterior-posterior (AP)
−4.2 mm, mediolateral (ML) ±2.5 mm from bregma, dorsoventral
(DV) −3.0 mm from dura; or AP −2.8 mm, ML ±2.3 mm from
bregma, DV −3.5 mm from skull surface, cannula at an angle of 15°
AP. PRh cannulae were implanted at AP−5.6 mm,ML±4.5 mm from
bregma, DV−5.7 mm from skull surface, at an angle of 20° ML; or at
AP −5.6 mm, ML ±4.5 mm from bregma, DV −6.70 mm from skull
surface, at an angle of 20° ML. For mPFC infusions, cannulae were
inserted at AP +3.20 mm, ML ±0.75 mm, DV −3.5 mm, all relative
to bregma.
Following surgery, all rats received 5 ml saline s.c. for fluid
replacements and 0.05 ml Vetergesic i.m. for analgesia and were
allowed to recover in single housing for two weeks. Animals were
then rehoused in pairs before behavioural procedures began.
Obturators (Plastics One) were used to keep the cannulae patent in
between infusions.2.3. Infusions
20 mg/ml stock solutions of RG108 (Abcam, UK) and
5-aza-2′-deoxycytidine (5AZA; Sigma-Aldrich, UK) were made up in
0.08% acetic acid and in 100% DMSO, respectively. 15 mg/ml stock
solutions of trichostatin A (TSA; Tocris, UK) were made up in 100%
DMSO. Working solutions of 200 μg/ml (RG108 and 5AZA) or 0.6 mg/
ml (for TSA) weremade up fresh for each experiment by diluting with
sterile 0.9% saline solution (Aqupharm No1, Animalcare Limited, UK).
The drug concentrations chosen were based on effective doses used in
previous studies (Miller and Sweatt, 2007; Zhao et al., 2010; Maddox
and Schafe, 2011; Wang et al., 2014; Barbier et al., 2015) and on
published IC50 values (Furumai et al., 2001; Khan et al., 2008). Rats
were infused bilaterally into HPC, PRh or mPFC with either drug or the
respective vehicle. For DNMT inhibitors RG108 and 5AZA, the infusion
took place immediately after the sample phase of the task so as to
examine effects on memory consolidation without disrupting mem-
ory encoding, as previous studies have identified a role for DNMTs
during memory consolidation (Miller and Sweatt, 2007; Sui et al.,
2012; Monsey et al., 2011). HDAC inhibitor TSA was infused 15 min
prior to the start of the sample phase to ensure the drug exerts its
effects during memory encoding, in line with previous studies that
found changes in histone acetylation during memory encoding
(Korzus et al., 2004; Fontán-Lozano et al., 2008; Wang et al., 2014).
For the infusions a 33 gauge cannula (Plastics One) was attached to a
0.025 ml Hamilton syringe via polyethylene tubing and inserted into
the implanted cannula. Infusions were performed over 2 min at
0.25 μl/min into HPC and at 0.5 μl/min into cortical areas. The volumes
used have been shown to achieve a drug spread of approximately 0.5–
2.5 mm from the injection site and were shown to be restricted to the
PRh for intraperirhinal infusions (Martin, 1991; Attwell et al., 2001;
Barker and Warburton, 2015). Infusion cannulae where left in situ for
5 min after the end of infusion to allow for diffusion of the infusate. All
experiments were run using a cross-over design and each animal was
re-tested following a minimum 3 days rest period.
2.4. Apparatus
All behavioural testing took place in a wooden, open-topped arena
(50 × 90 × 100 cm), the floor of which was covered with sawdust.
For the novel object recognition (NOR) task, all four walls were grey
and the arena was surrounded with a black cloth up to a height of
1.5 m to conceal the experimenter. For the object-in-place (OIP) task,
one of the walls was substituted with a black wall and the curtains
were removed from two sides of the arena to provide extra-maze
cues. The rats' behaviour was recorded via an overhead camera and a
computer. Objects used in the behavioural tasks were made out of
Duplo® (Lego UK, Slough, UK) in varying size, shape and colour. The
objects were cleaned with 100% ethanol before each run to eliminate
olfactory cues.
2.5. Behavioural testing
Before object recognition testing began, rats were habituated to
the arena for 5 min daily for 5 days and handled regularly. Rats were
subjected to two tasks – the novel object recognition (NOR) and the
object-in-place (OIP) tasks (see Fig. 1). Each task consisted of a sample
phase of variable length and a choice phase of 180 s length separated
by a delay of 24 h, which the rat spent in its home cage.
2.5.1. NOR task
For the sample phase two identical copies of an object (objects A1
and A2) were placed in adjacent corners of the arena (see Fig. 1a). The
rat was placed in the arena facing the centre of the opposite wall and
was allowed to explore the objects for 40 s or until it had spent a total
of 240 s in the arena, whichever occurred soonest (‘standard sample
Fig. 1. Schematic representation of object recognition tasks. In the NOR task (a) normal
rats are expected to spend more time exploring the novel object (B) during the choice
phase. In the OIP task (b) normal rats spend more time exploring the object pair in the
novel configuration (C and D) compared to the pair that has remained in the same
locations.
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hypothesised that an enhancement of memory performance might be
observed, we also used a sample phase in which the rat was allowed a
maximum cumulative object exploration of 20 s or a total of 120 s in
the arena (‘subthreshold sample phase’). Following a 24 h delay,
memory performance was assessed in a choice phase of 180 s. During
this phase a third copy of object A (A3) and a novel object (object B)
were placed into the arena (Fig. 1a). The position of the novel
object (left or right) and the objects used as novel or familiar were
counterbalanced across animals.
2.5.2. OIP task
In the sample phase, four different objects (A, B, C and D) were
placed 10 cm from the corners of the arena (Fig. 1b). Each rat was
allowed to explore the objects for 300 s. In the histone deacetylation
experiments, a subthreshold sample phasewas used, wherein animals
were allowed a maximum cumulative object exploration of 25 s or a
total of 120 s in the arena. After the 24 h delay, recognition memory
performance was assessed in a test phase of 180 s duration in which
the animal was placed back into the arena, which contained objects A,
B, C and D, but two of the objects (e.g. C and D) had exchanged
positions (the moved objects) while the other objects (A and B)
remained in the same position (the unmoved objects) (Fig. 1b). The
position (left or right) of the object pairs during the sample phase
and the moved object pair in the test phase were counterbalanced
between rats.
2.6. Statistical analysis
The time spent exploring the novel and familiar objects in the NOR
choicephase or the unmoved andmovedobjects in theOIP choice phase
was recordedwith the experimenter blind to the drug status of each rat.
Exploration was defined as the animal directing its nose towards the
objectwithin a distance of 2 cm. The discrimination ratiowas calculated
as the difference in time between exploring the novel and familiar
objects (or object-place pairings) divided by total exploration time.
Groups were compared using two-way, repeated-measures analysis of
variance (ANOVA). The within-subjects factor was infusion (vehicle vs
drug) for both experiments and the between-subjects factor was drugtype (RG108 vs 5AZA) for the DNA methylation experiments and
sample phase type (subthreshold or standard) for the histone
acetylation experiments. Bonferroni-corrected multiple comparisons
were performed where applicable and one-sample t-tests against a
discrimination ratio of zero (equal exploration of novel and familiar
object) were used to analyse whether the animals had discriminated
between the objects. For all statistical analyses a significance level of
0.05 was used.
2.7. Histology
At the end of the behavioural experiments, the rats were
anaesthetised with Euthatal (Rhȏne Mérieux) and perfused transcar-
dially with 0.1 M phosphate buffer (pH 7.4), followed by 4% parafor-
maldehyde. After postfixation in paraformaldehyde for 24 h the brain
was incubated in 30% sucrose in 0.2 M phosphate buffer for 48 h.
Coronal sections were cut at 40 μm on a cryostat, mounted onto slides
and stained with cresyl violet. Correct placement of the cannulae was
confirmed under a light microscope using a rat brain atlas (Paxinos and
Watson, 1998). Cannula tips of all rats were confirmed to be present in
dorsal HPC, PRh and mPFC, as expected (Fig. 2).
3. Results
3.1. Infusion of RG108 or 5AZA into the HPC impaired object-in-place but
not novel object recognition memory
DNMT inhibitors RG108 or 5AZA were infused into the HPC
immediately after the sample phase of an OIP task. Compared to
vehicle-infused rats, rats that had been administered RG108 or
5AZA showed reduced discrimination in the OIP task (Fig. 3a).
Repeated-measures ANOVA showed a significant main effect of
infusion (F1,30 = 15.6, p = 0.0004). No significant effect of drug
type (F1,30 = 0.257, p = 0.616) and no significant infusion × drug
type interaction (F1,30 = 2.11, p = 0.157) was observed. Post-hoc
comparisons revealed that performance after RG108 infusion was
significantly different to performance after vehicle infusion (t11 =
3.42, p = 0.004) while performance of 5AZA-infused rats was not
significantly different compared to control rats (t19 = 2.039, p =
0.1006). Furthermore, rats infused with vehicle showed significant
discrimination between the novel and familiar configurations (RG108,
t11 = 3.04, p = 0.011; 5AZA, t19 = 2.66, p = 0.016) whereas perfor-
mance in the task was disrupted after infusion of either RG108
(t11 = −1.58, p = 0.143) or 5AZA (t19 = 0.54, p = 0.59).
Next the effect of DNMT inhibition was tested in the NOR task. As can
beseen inFig. 3b, rats treatedwithvehicleoreitherof theDNMT inhibitors
were able to discriminate in the task. Two-way ANOVA showed no
significantmain effect of infusion (F1,23 = 0.018, p = 0.893) or drug type
(F1,23 = 4.14, p = 0.054) and no significant infusion × drug type
interaction (F1,23 = 0.042, p = 0.839). Vehicle-infused rats showed
significant discrimination between novel and familiar objects (RG108,
t11 = 3.41, p = 0.006; 5AZA, t11 = 4.36, p = 0.001), as did rats that
had received RG108 (t11 = 2.34, p = 0.039) or 5AZA (t11 = 5.80,
p = 0.0001).
The effect of RG108 or 5AZA infusion on total exploratory behaviour
during the choice phasewas also analysed (Table 1). No differences in the
total amount of exploration during the OIP task were observed,
confirmed by a non-significant main effect of infusion (F1,30 = 0.578,
p = 0.453), a non-significant effect of drug type (F1.30 = 0.034, p =
0.854) and a non-significant infusion × drug type interaction (F1,30 =
0.027, p = 0.872). In theNOR task, therewas no significantmain effect of
infusion (F1,23 = 0.992, p = 0.812) and no significant infusion × drug
type interaction (F1,23 = 0.547, p = 0.467) however there was a
difference in the total amount of object exploration between the two
types of drug (main effect of drug type, F1,23 = 122.7, p b 0.0001).
Further analyses revealed that the behaviour of vehicle-infused rats in the
Fig. 2. Placement of infusion cannulae. a. Infusion cannulae tips (black dots) were located in the dorsal hippocampus (bregma −4.2 mm, −3.8 mm; a), in the perirhinal cortex
(bregma −5.6 mm, −4.80 mm; b) and in the mPFC (bregma +4.20 mm; c). Several of the dots overlap. Images of coronal sections adapted from Paxinos and Watson (1998).
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with RG108 (t46 = 7.64, p b 0.0001) or corresponding vehicle (t46 =
6.50, p b 0.0001).Fig. 3. Effect of DNMT inhibition in the HPC on consolidation of OIP and NORmemory. Rats w
OIP (a; RG108: n = 13; 5AZA: n = 20) or a NOR task (b; RG108: n = 12; 5AZA: n = 13) w
apply to both drug and respective control group. Age range of rats at time of experiment: 3–1
discrimination ratio of zero, #p b 0.05, ##p b 0.01, ###p b 0.001.These results indicate that infusion of DNMT inhibitor RG108 or
5AZA into the HPC immediately after the sample phase significantly
impaired OIP but not NOR performance.ere infused into the HPC with RG108 or 5AZA immediately after the sample phase of an
ith a 24 h delay. The mean discrimination ratio (±s.e.m.) is shown. n numbers given
1 months. Statistical differences between infusion groups, ⁎⁎p b 0.01. Significance from
Table 1
Total exploration in the NOR and the OIP tasks after DNMT inhibition. Mean exploration
time ± s.e.m. during the choice phase is shown for rats infused with either vehicle or
drug (RG108 or 5AZA) into the HPC, PRh or mPFC.
Task Drug Total exploration (s)
Vehicle Drug
HPC NOR RG108 63.32 (4.08) 69.41 (4.43)
5AZA 33.68 (1.83) 34.58 (2.06)
OIP RG108 74.24 (4.15) 77.69 (4.48)
5AZA 73.82 (4.12) 76.05 (4.80)
PRh NOR RG108 50.31 (6.03) 40.05 (5.23)
5AZA 39.37 (2.89) 38.89 (3.00)
OIP RG108 90.25 (5.82) 103.84 (4.21)
5AZA 49.49 (2.78) 51.68 (3.19)
mPFC OIP RG108 77.85 (5.06) 86.24 (4.28)
5AZA 88.03 (4.82) 83.30 (5.20)
Fig. 5. Effect of DNMT inhibition in the mPFC on an OIP memory task. Rats were infused
with RG108 (n = 12) or 5AZA (n = 12) into the mPFC immediately after the sample
phase of an OIP task. The mean discrimination ratio achieved during the choice phase
after a 24 h delay is depicted (+s.e.m.). n numbers given apply to both drug and
respective control group. Age range of rats at time of experiment: 3–11 months
Significance from discrimination ratio of zero, ##p b 0.01.
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recognition and object-in-place memory
The effect of intra-perirhinal infusion of RG108 or 5AZA on NOR
memory performance can be seen in Fig. 4a. Statistical analysis
revealed a significant main effect of infusion (F1,19 = 6.03, p = 0.024)
and a significant infusion × drug type interaction (F1,19 = 5.06, p =
0.037). Further analysis confirmed that RG108-infused animals were
significantly impaired in the NOR task compared to rats that had
received vehicle (t8 = 3.11, p = 0.012). While vehicle-infused rats
were able to discriminate between the novel and the familiar object
(RG108 experiment, t8 = 3.86, p = 0.005; 5AZA experiment, t11 =
4.40, p = 0.001), only rats infused with the inhibitor 5AZA showed
significant discrimination in the task (R108, t8 = 0.81, p = 0.44; 5AZA,
t11 = 5.08, p = 0.034).
Performance in the OIP task was impaired after post-sample
infusion of RG108, but not 5AZA, into the PRh (Fig. 4b). A significant
main effect of drug type (F1,18 = 6.07, p = 0.024) and a significant
infusion × drug type interaction (F1,18 = 6.80, p = 0.018) was
observed. Furthermore there was a significant difference in discrim-
ination between RG108 and vehicle-treated rats (t7 = 2.55, p =
0.040). Rats that had received vehicle showed significant discrimina-
tion between the novel and the familiar object in the RG108
experiment (t7 = 2.83, p = 0.025) while in the 5AZA experiment
vehicle-infused rats were able to discriminate between the two
objects but this did not reach statistical significance (t11 = 2.14, p =
0.06). Rats infused with 5AZA, but not RG108, were able to
discriminate in the OIP task (RG108, t7 = 1.36, p = 0.22; 5AZA,
t11 = 5.07, p = 0.0004).
No differences in total amount of exploration between vehicle and
DNMT inhibitor infusions were observed in either task (Table 1),Fig. 4. Effect of DNMT inhibition in the PRh on consolidation of NOR and OIP memory. Immediately after the sample phase of a NOR (a; RG108: n = 9; 5AZA: n = 12) or an OIP task
(b; RG108: n = 8; 5AZA: n = 12), rats received a RG108 or 5AZA infusion into the PRh. The mean discrimination ratio (±s.e.m.) after a 24 h delay is shown. n numbers given apply
to both drug and respective control group. Age range of rats at time of experiment: 3–11 months. Statistical differences between infusion groups, ⁎p b 0.05, ⁎⁎p b 0.01. Significance
from discrimination ratio of zero, #p b 0.05, ##p b 0.01, ###p b 0.001..confirmed by a non-significant main effect of infusion (NOR, F1,19 =
1.01, p = 0.327; OIP, F1,18 = 2.64, p = 0.954) and a non-significant
infusion × drug type interaction (NOR, F1,19 = 0.840, p = 0.371; OIP,
F1,18 = 1.38, p = 0.256). A significant main effect of drug type was
observed in the OIP task only (NOR, F1,19 = 3.39, p = 0.081; OIP,
F1,18 = 207.1, p b 0.0001). Specifically, there was a significant
difference in exploration behaviour between vehicle-infused rats
from the 5AZA experiment and drug (t6 = 8.94, p b 0.0001) or
vehicle-treated rats in the RG108 experiment (t6 = 6.99, p b 0.0001).
Thus, infusion of RG108 into the PRh significantly impaired
performance in both the NOR and OIP tasks while infusion of 5AZA
in the PRh did not affect performance in the NOR or the OIP task.
3.3. Infusion of RG108 or 5AZA into the mPFC reduced performance in
the object-in-place task
Rats were infused with either RG108 or 5AZA into the mPFC and
tested on the OIP task only as it has been demonstrated extensively
that the mPFC is not required for NORmemory (Ennaceur et al., 1997;
Mitchell and Laiacona, 1998; Hannesson et al., 2004; Barker et al.,
2007). As shown in Fig. 5, discrimination in the OIP task was reduced
after RG108 or 5AZA infusion compared to vehicle administration.
Statistical analysis indicated a significant main effect of infusion
(F1,22 = 5.651, p = 0.027) but no significant main effect of drug type
(F1,22 = 0.151, p = 0.701) and no significant infusion × drug type
interaction (F1,22 = 0.035, p = 0.852). Further analysis revealed that
neither RG108 nor 5AZA-infused animals were significantly impaired
in the OIP task compared to rats that had received vehicle (RG108,
t11 = 1.85, p = 0.202; 5AZA, t11 = 4.61, p = 0.055). While
vehicle-infused rats were able to discriminate between the moved
Table 2
Total exploration in the NOR and OIP tasks after HDAC inhibition. Mean exploration
time ± s.e.m. during the choice phase is shown for rats infused with either vehicle or
TSA. Infusions were made into the PRh and rats were subjected to the NOR task while
rats infused in the mPFC underwent OIP testing.
Task Sample
phase
Total exploration (s)
Vehicle TSA
PRh NOR Subthreshold 24.47 (1.95) 30.52 (4.17)
Standard 25.19 (2.67) 26.14 (3.75)
mPFC OIP Subthreshold 37.27 (1.94) 34.58 (1.74)
Standard 34.38 (2.09) 36.20 (3.28)
6 H. Scott et al. / Neuroepigenetics 9 (2017) 1–9and the unmoved objects (RG108 experiment, t11 = 3.757, p =
0.003; 5AZA experiment, t11 = 4.09, p = 0.002), rats infused with
RG108 or 5AZA did not show significant discrimination (RG108,
t11 = 0.731, p = 0.480; 5AZA, t11 = 0.27, p = 0.793).
The total amount of exploration in the choice phase did not differ
betweenvehicle andRG108or 5AZA infusions into themPFC (Table 1), as
there were no significant main effects of either infusion (F1,22 = 0.168,
p = 0.685) or drug type (F1,22 = 0.481, p = 0.495) and a
non-significant infusion × drug type interaction was observed
(F1,22 = 2.166, p = 0.155).
Taken together, the results suggest that both RG108 and 5AZA
infusions into the mPFC cause a reduction in the ability of the rat to
discriminate in the OIP task.
3.4. Infusion of TSA into the PRh led to robust object recognition memory
after a subthreshold sample phase
To inhibit histone deacetylation, TSA was infused into the PRh
15 minbefore the start of the sample phase of aNOR task. As canbe seen
in Fig. 6, animals that received TSA infusion showed normal perfor-
mance in both subthreshold and standard sample phase versions of the
NOR task, whereas vehicle-infused animals did not show significant
discrimination when the subthreshold sample phase was used.
Two-way ANOVA showed no significant main effect of infusion
(F1,22 = 1.43, p = 0.244) or sample phase type (F1,22 = 0.306, p =
0.586), and no significant infusion × sample phase type interaction
(F1,22 = 0.482, p = 0.495). Vehicle-infused rats showed significant
discrimination between novel and familiar objects after a standard
(t11 = 2.88, p = 0.015) but not subthreshold (t11 = 1.33, p = 0.210)
sample phase. Conversely, TSA-infused animals showed significant
discrimination after both sample phase types (subthreshold t11 = 2.98,
p = 0.013; standard t11 = 3.64, p = 0.004).
The effect of TSA infusion on total exploratory behaviour in the
choice phasewas also analysed (Table 2). Therewas no significantmain
effect of either infusion (F1,22 = 1.65, p = 0.212) or sample phase type
(F1,22 = 10.3, p = 0.263), and no significant infusion × sample phase
type interaction (F1,22 = 0.873, p = 0.360).
These results suggest that TSA infusions into the PRh lead to robust
long-term object recognition memory, even after a subthreshold
sample phase.
3.5. Infusion of TSA into the mPFC had no effect on object-in-place
associative recognition memory
To investigate the role of histone acetylation in associative
recognition memory, TSA was infused into the mPFC 15 min prior to
the sample phase of the OIP task. As is shown in Fig. 7, TSA infusion did
not influence performance in either the standard or the subthresholdFig. 6. Effect of HDAC inhibition in the PRh on encoding of NOR memory. Immediately
before the standard (n = 12) or subthreshold (n = 12) sample phase of a NOR task,
rats received an infusion of either TSA or vehicle into the PRh. The mean discrimination
ratio (+s.e.m.) after a 24 h delay is shown. n numbers given apply to both drug
and respective control group. Age range of rats at time of experiment: 3–11 months.
Significance from discrimination ratio of zero, #p b 0.05, ##p b 0.01.versions of the OIP task. Statistical analysis found no significant main
effect of infusion (F1,22 = 0.126, p = 0.726), but did reveal a main
effect of sample phase type (F1,22 = 12.4, p = 0.002). However, there
was no significant infusion × sample phase type interaction (F1,22 =
0.694, p = 0.414). Further analysis using paired t-tests indicated that
in the OIP task vehicle-infused animals performed significantly better
after a standard sample phase compared to a subthreshold sample
phase (t22 = −2.95, p = 0.007), whereas for TSA-infused animals
this difference was not significant (t22 = −1.76, p = 0.093). After a
standard sample phase, both vehicle- (t11 = 5.35, p b 0.0005) and
TSA-infused (t11 = 3.19, p = 0.009) animals showed significant
discrimination between familiar and novel object-location combina-
tions. Conversely, after a subthreshold sample phase neither vehicle
(t11 = 0.516, p = 0.616) nor TSA-infused (t1,11 = 1.27, p = 0.230)
animals showed significant discrimination.
Analysis of total object exploration in the choice phase (Table 2)
revealed no significant main effect of either infusion (F1,22 = 0.031,
p = 0.861) or sample phase type (F1,22 = 0.083, p = 0.776), and no
statistically significant infusion × sample phase type interaction
(F1,22 = 0.845, p = 0.368).
Together these results suggest that infusion of TSA into the mPFC
does not affect performance in the OIP task after either a subthreshold
or standard sample phase.4. Discussion
In the present study we investigated the roles of two epigenetic
mechanisms, DNAmethylation and histone acetylation, in recognition
memory function. By using targeted infusions of inhibitors against
DNMTs or HDACs, we have identified that DNA methylation and
histone deacetylation play contrasting roles in recognition memory.Fig. 7. Effect of HDAC inhibition in the mPFC on an OIP memory task. Rats were infused
with TSA into the mPFC immediately before the standard (n = 12) or subthreshold
(n = 12) sample phase of an OIP task. The mean discrimination ratio (+s.e.m.) after a
24 h delay is shown. n numbers given apply to both drug and respective control group.
Age range of rats at time of experiment: 3–11 months. Statistically significant
differences between sample phase types, **p b 0.01. Significance from discrimination
ratio of zero, ##p b 0.01, ###p b 0.001.
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We have shown for the first time that DNAmethylation in the PRh
is required for single-item recognition memory and that DNA
methylation in the mPFC is required for object-place associative
recognition memory. In agreement with previous studies (Mitchnick
et al., 2015), we have also found that associative recognition memory
relies on DNMT function in the PRh and in the HPC.
Taken together the results suggest that DNA methylation is
essential for the familiarity discrimination component of recognition
memory (which relies on the integrity of the PRh) as well as for the
integration with the associative component of recognition memory
(which is dependent on both the HPC and mPFC). The consolidation
of single-item and associative recognition memory are both
supported by changes in synaptic strength as long-term depression
(LTD) is the predominant mechanism underlying familiarity dis-
crimination in the PRh (Brown and Xiang, 1998; Griffiths et al.,
2008), while it is long-term potentiation (LTP) in the HPC and mPFC
that has been found to play a role in recognition memory
consolidation (Clarke et al., 2010; Xiang and Brown, 2004; Hirsch
and Crepel, 1991). In order for these synaptic plasticity processes to
facilitate the formation of long-term memories, long-lasting bio-
chemical alterations at the synapse level, mediated by gene
expression changes are also required. LTP has previously been
shown to be associated with DNA methylation in HPC and mPFC
(Feng et al., 2010; Levenson et al., 2006; Miller and Sweatt, 2007;
Morris et al., 2014; Sui et al., 2012). The observation that DNMT
function in the PRh is required for familiarity discrimination,
suggests that DNA methylation may also be linked to LTD in the
PRh. Hence DNA methylation may have a more general role in
recognition memory function, independent of brain region or
underlying plasticity process. Since DNA methylation at gene
promoters has been associated with transcriptional repression
(Brenet et al., 2011), DNMT inhibition may impair recognition
memory consolidation by inhibiting methylation of genes known to
be negative regulators of memory formation, such as protein
phosphatase 1 and calcineurin (Miller and Sweatt, 2007; Miller et
al., 2010). Alternatively, the DNMT inhibitor may exert its effect by
inhibiting the exonic methylation of plasticity genes, thereby
affecting production of alternative transcripts (Lubin et al., 2008)
and reducing the capability of the neuron to ‘fine-tune’ its neuronal
properties.
Two different types of DNMT inhibitor, RG108 and 5AZA, were
used in this study. Both drugs produced comparable effects when
infused into the HPC or mPFC. In contrast, only RG108, and not 5AZA,
infusion into the PRh caused impairment in the recognition memory
tasks. It should be mentioned that vehicle-infused rats in the 5AZA
experiment did not show significant discrimination in the OIP task.
However, the significant discrimination of rats infused with 5AZA
along with the lack of a significant difference between performances
in the task by vehicle or 5AZA-infused rats, supports the interpreta-
tion that 5AZA infusion, in contrast to RG108 infusion, did not impair
performance in either recognitionmemory task. DNMT inhibitor 5AZA
is a cytosine analogue that blocks DNMT function by covalently
binding to the enzyme's catalytic cysteine residue (Santi et al., 1983,
Santi et al., 1984) and may require incorporation into the DNA strand
to exert its inhibitory effect (Creusot et al., 1982; Stresemann et al.,
2006). In contrast, RG108 is a non-nucleoside inhibitor that acts by
reversibly blocking DNMT's active site, without requiring incorpora-
tion into the DNA strand (Brueckner et al., 2005). In addition, RG108 is
considered to be less likely to show non-specific effects, as it was
modelled specifically to fit the active pocket of DNMT1 (Brueckner et
al., 2005). While it is clear that the two inhibitors may have different
mechanisms of action it is of great interest to establish the
mechanistic and functional differences between them in order to
elucidate the differential effects on DNMT function in the PRh.4.2. The role of HDACs in recognition memory
This is the first study demonstrating that direct infusion of a
general HDAC inhibitor into the PRh can lead to robust object
recognition memory after a subthreshold sample phase in the NOR
task. This result concurs with previously published observations in
which systemic injections of TSA enhanced object recognition
memory after a subthreshold sample phase (Fontán-Lozano et al.,
2008). No enhancement in memory was seen following a standard
sample phase with TSA infusion. This result is in agreement with
findings from other researchers in which HDAC inhibition with either
TSA or sodium butyrate had no effect on object recognition memory
after a standard sample phase (Korzus et al., 2004; Stefanko et al.,
2009).
In contrast to the improvement in memory function seen when
HDACs were inhibited in the PRh in the object recognition task,
infusion of TSA into the mPFC did not lead to robust memory of
object-place associations in the OIP task after a subthreshold sample
phase. However, other studies have shown that increases in histone
acetylation in the mPFC enhanced fear extinction (Bredy et al., 2007)
and trace fear memory (Sui et al., 2012). It is possible therefore that
the effects of histone acetylation in memory may be task-specific,
however a recent study using the OIP task found that HAT inhibition in
the HPC and PRh impaired associative recognition memory (Mitch-
nick et al., 2016), indicating that histone acetylation in other brain
areas is required for OIP task performance.
Taken together, these findings suggest that histone acetylation
enhances the PRh-dependent familiarity discrimination component
of recognition memory, but does not affect the mPFC-dependent
integration of object and place associations in recognition memory.
HDACs have previously been shown to be involved in mediating
the changes in synaptic strength thought to underlie memory.
Application of HDAC inhibitors enhanced LTP in hippocampal,
prefrontal and amygdala slices (Alarcon et al., 2004; Levenson et
al., 2004; Yeh et al., 2004; Vecsey et al., 2007;Miller et al., 2008; Sui et
al., 2012). Our finding that HDAC inhibitor infusion into the PRh
enhances object recognition memory suggests that HDACs mediate
synaptic plasticity in this brain region. However, there are as of yet no
published studies investigating this mechanism. In other brain areas,
studies of LTD, the mechanism thought to underlie familiarity
discrimination in the PRh (Brown and Xiang, 1998; Griffiths et al.,
2008), have yielded conflicting results, finding alternately that HDAC
inhibitor may have no effect on (Alarcon et al., 2004) or may even
block (Guan et al., 2002; Hanson et al., 2013) LTD. Further study is
therefore required to determine whether HDAC inhibition in the PRh
produces an enhancement in LTD concurrent with the enhancement
observed in object recognition memory. We have shown that HDAC
inhibition, which has been shown to enhance LTP in acute prefrontal
slices (Sui et al., 2012), did not enhance associative recognition
memory. These studies point towards a selective role of histone
deacetylation in recognition memory function, which is task
dependent and may or may not be directly coupled to underlying
mechanisms of synaptic plasticity.
The enhancement observed in familiarity discrimination following
TSA infusion into the PRh is in line with the molecular brake pad
hypothesis, which states that HDACs act as ‘brakes’, opposing the
action of constitutively active HATs (McQuown and Wood, 2011). In
McQuown and Wood's model, HDAC inhibitors remove the HDAC
‘brakes’, leading to an increase in HAT-mediated histone acetylation at
the promoters of plasticity-related genes, thereby increasing the
expression of these genes, leading to enhanced synaptic plasticity and
memory. In animal studies, inhibition of HDAC activity has been
shown to increase the acetylation and expression of genes including
Arc, c-Fos, Bdnf, Egr-1, Camk2a, Creb1 and Gria1, concomitant with
enhancements in memory (Guan et al., 2009; Graff et al., 2014).
Future studies using inhibitors that are selective for specific classes of
8 H. Scott et al. / Neuroepigenetics 9 (2017) 1–9HDACswill provide amore detailed understanding of the contribution
of different HDAC subtypes to recognition memory.
Recently HDACs have been reported to deacetylate non-histone
substrates including transcription factors, signalling proteins and RNA
binding proteins (Spange et al., 2009). In addition to their epigenetic
function HDACs could therefore also play a part in recognition
memory formation and consolidation by regulating additional factors
involved in transcription and RNA processing.
5. Conclusion
Increases in DNMT expression and histone acetylation have been
seen to occur concomitantly as a consequence of LTP or memory
formation in various brain regions and tasks (Monsey et al., 2011; Sui
et al., 2012). In fact, DNMTsmay interact directly with HDACs (Fuks et
al., 2001; Ling et al., 2004) and DNA methylation sites can act as a
recruitment point for HDACs, which induce modification of chromatin
structure and further transcriptional repression (Jones et al., 1998; Ng
et al., 1999). Infusions of the HDAC inhibitor TSA are able to
ameliorate impairments in memory and synaptic plasticity seen as a
result of DNMT inhibition in HPC- and amygdala-dependent tasks
(Miller et al., 2008; Maddox and Schafe, 2011; Monsey et al., 2011).
The presented results support the hypothesis that both DNA
methylation and histone acetylation play crucial roles in the
regulation of gene changes that underlie recognition memory in the
PRh. Further experiments in which DNMT and HDAC inhibitor
infusions are performed together would need to be carried out to
investigate whether DNAmethylation and histone acetylationwork in
concert to produce perirhinal recognition memory.
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